ã¡ãã£ã¢èšäº
æ¥æ¬çºãã€ãã«ã¡ã¯ãã³ããã€ã³ããã³ããæ²»çã§ææè
æ°æžãWHOãå察ãã®ããŒ
ããºãææ°ããŒã¯ 619
twitterã³ã¡ã³ã 935ä»¶äž 201ïœ300件
â»ã€ã³ãããã«ãŒãã¢ããªã«è«žåœã§é¡èãªå¹æãã¯ã¯ãã³ãããã¯ããã«å®å
šãªã€ãã«ã¡ã¯ãã³ãæ©ãæ¿èªãã¹ãã ã
ããã¯ã©ãããæ©åºãªã®ã§ãããããã
ã€ã³ããªã©ã§ã®å¯çè«ã«å¹ãã®ã§ããããã
ã€ã³ããªã©ã§ã®å¯çè«ã«å¹ãã®ã§ããããã
ãã€ã³ã åå·ãæå¯çè«ç
ã®ç¹å¹è¬ãã€ãã«ã¡ã¯ãã³ãã®æ¬æ Œæäžã«èžã¿åã£ãŠãããææè
æ°ã»æ»äº¡è
æ°ãšãã«æžå°ã«è»¢ããŠããã
æ¥æ¬ã¯ã¯ã¯ãã³ã®å¯äœçšã§åççãæ眪å€æ±ºãåããéå»ã«ãã
ãªããªãããçšã«ã¯èªå¯ããªããã ããª
æ¥æ¬ã¯ã¯ã¯ãã³ã®å¯äœçšã§åççãæ眪å€æ±ºãåããéå»ã«ãã
ãªããªãããçšã«ã¯èªå¯ããªããã ããª
åŸåã«ç«æ²ã®ååãèŠããŠäžæ°ã«è¡æ£èããåºãŠãã
ããããã·ã¯ãããã³(HCQ)ãšåããå®ããŠå¹æã®ããè¬ã¯äœ¿ãããªããæ¬åœã«è£œè¬æ¥çã¯è
æããŠããã補è¬æ¥çå¯ãã®Facebookã§ãHCQã®å¹èœã¯åŠå®ã§ããªãã£ã
èšäºãèªãéããæ¢ã«ã€ã¿ãªã¢ã»ã€ã®ãªã¹ã»æ¥æ¬ã»ãã©ã³ã¹ã»ã¢ã¡ãªã«ãªã©ã®å
é²åœã§ãæ²»éšãéå§ãããŠãããšã®ããšãªã®ã§ãèªãã§ã¿ãŠãããããªãšã
åéç 究æã®ãµã€ãã§ããã®ä»¶ã«é¢ããŠã¯ããªã詳现ãªæ å ±ãèŒã£ãŠããŸããã
åéç 究æã®ãµã€ãã§ããã®ä»¶ã«é¢ããŠã¯ããªã詳现ãªæ å ±ãèŒã£ãŠããŸããã
çç±ã¯ïŒã€ãããããã§ããã
éãéãããšéã§ã
éãéãããšéã§ã
ãªãããã€ãã¹ããŒãªã®ã§ãã
ãèªæ°å
ã¯è£œè¬æ¥çã®å§åãåå ãªãå®ã®æã¡è
ãã§ãè
éŠçžã
æ¥æ¬ãã¯ã¯ãã³ã§ã¯ãªãã€ãã«ã¡ã¯ãã³ãâŒïž
äžåœã¯ãã®ã€ãã«ã¡ã¯ãã³ã çšéç¹èš±ãšã£ã¡ããã®ã ãããïŒ
ãã£ã±ãðã®ã»ããå²ããã ååŽçã¯åãããããªããâŠ
ãã£ã±ãðã®ã»ããå²ããã ååŽçã¯åãããããªããâŠ
ã€ã³ããªã©ã§
ãã€ãã«ã¡ã¯ãã³ãã§ææè æ°ã»æ»äº¡è æ°ãšãã«æžå°ïŒ
ããŒãã«è³ãåè³ãã倧ææºããã®çºèŠ
ãã¯ãæ¥æ¬äººã¯åãã£ãïŒ
æ¥æ¬æ¿åºãé ãããäºå®ã§ããããð
ãã€ãã«ã¡ã¯ãã³ãã§ææè æ°ã»æ»äº¡è æ°ãšãã«æžå°ïŒ
ããŒãã«è³ãåè³ãã倧ææºããã®çºèŠ
ãã¯ãæ¥æ¬äººã¯åãã£ãïŒ
æ¥æ¬æ¿åºãé ãããäºå®ã§ããããð
æ¥æ¬çºã ã€ã³ããã³ããæ²»çã§ææè
æ°æžãWHOãå察ãã®ããŒ
ããäžå¹Žåãèšãç¶ããŠç²ãããã©ãæ²»çè¬ãšããŠæåŸ
åºæ¥ãäžã«æ¥æ¬ã®å€§æå
çã®è¬å€ãªãã ããäœã§ããã«æ¿èªããªãã®ãç解ã«èŠãããððŠ
WHOã¯æ¬æ¥ãããªããã°ãªããªãæ¥åã®çéããã£ãŠãããäžæ»ã«å€ããïŒïŒäººé¡ã®æµã ã
èšäºãèªããšã¹ãŽã€å¹æãããããªãšåºãŠããã®ã«ã»ã»ã»è¬ã®ãéïŒãã§ãã
ã©ãããŠãªãã§ããããð
ãããããã°ã¯ã¯ãã³äžçšã§ãããããªãæ¥æ¬ã¯ãããæ¿èªããªãã®ããæ¥æ¬æ¿åºã«ã¯äžä¿¡æãããªãã
ãã€ãã«ã¡ã¯ãã³ã
æ°åã³ãããžã®æå¹æ§ã瀺åããããŒã¿ã¯ããã¶ãéãŸã£ãŠããŠããããã ãã©ããªãæ¿èªããªãã®ã ããããã
æ°åã³ãããžã®æå¹æ§ã瀺åããããŒã¿ã¯ããã¶ãéãŸã£ãŠããŠããããã ãã©ããªãæ¿èªããªãã®ã ããããã
é 匵ããæ¥æ¬è¬ïŒ
äžçãæã£ãŠãã ããïŒïŒ
äžçãæã£ãŠãã ããïŒïŒ
èªå¯ãããŠãªããšå¯äœçšã®ãšãã«ãå»è
æ§ã責åãè² ãã®ãã
â
â
ã¯ã¯ãã³=ææäºé²ãšã€ãã«ã¡ã¯ãã³=æ²»çè¬ã®å¹æããã£ã¡ãã«ããŠãªããïŒ
â«çŸåšãç«æ²æ°äž»å ãã€ãã«ã¡ã¯ãã³æ¿èªãåŸæŒãããè°å¡ç«æ³ãæºåããŠããŸã
äžæ°ã«è©±ãè¡æ£èããªã£ãâŠ
â«çŸåšãç«æ²æ°äž»å ãã€ãã«ã¡ã¯ãã³æ¿èªãåŸæŒãããè°å¡ç«æ³ãæºåããŠããŸã
äžæ°ã«è©±ãè¡æ£èããªã£ãâŠ
æ¥æ¬çºã®æ²»çè¬ãšããŠæåŸ
ãããã>>>
ãã€ãã«ã¡ã¯ãã³ãã€ã³ãã§ææè
æž
ããã§ãWHOãå察ð§
ããã§ãWHOãå察ð§
ããããç¹å¹è¬ãåŠå®ããŠã¯ã¯ãã³äžæã«ããæå³ãæããŠã»ããã
å»åž«ãšããŠãããããããšãå¹³ç¶ãšãã€ãŒãã§ããç¥çµãçã£ãŠããŸãã
ããã¯ã©ãã¹ã®èªããªããŠæŠå¿µã¯å šãç¡ããã ãããªã
å»åž«ãšããŠãããããããšãå¹³ç¶ãšãã€ãŒãã§ããç¥çµãçã£ãŠããŸãã
ããã¯ã©ãã¹ã®èªããªããŠæŠå¿µã¯å šãç¡ããã ãããªã
å®éå¹ãã®ã ããïŒãšããããAERAã ããªã»ã»
AERAãœãŒã¹ãªã®ãæ°ã«ãªããâŠ
ã€ãã«ã¡ã¯ãã³ãã³ããªãåããªâŠ
ã€ãã«ã¡ã¯ãã³ãã³ããªãåããªâŠ
ç§åŠçãªæ ¹æ ããã£ãŠæ¹å€ãããã«ã¯ãäžççã«è©äŸ¡ãããŠããããŒã¿ãèŠãªããã°ãããŸãããããããã ãããžãã£ããªããŒã¿ãéãŸã£ãŠãã以äžãç§åŠçãªåŠå®ã¯é£ããïŒ
åšäžåœãšãã¶ãã¶ã®è¡æ£èãWHOã»ã»ã»æš©åšãšæ¬§ç±³æšªæåã¢ã«ãã¡ãããïŒæåå£äœã«åŒ±ããã³åœäººéšãããã»ã»ã»
å»è¬åã¯éçºã«ãšãŠãéããããããããéå²ãã®ããã«ã¯äººã®åœãªããŠãªãã§ããªãããã§ãæ¢åè¬ã«é«ãå¹æããããšæ²»éšãã£é£ã°ããŠãè¡æ£èãã¯ã¯ãã³ãªããŠæ¿èªåºæ¥ãªããããªâŠå
šãŠã¯é
ã€ãã«ã¡ã¯ãã³ãäœæ
ååŽçã¯æ²»çè¬ãšããŠã®ç·æ¥äœ¿çšãèªããªãã®ã§ããïŒããããååŽçã®ãæ°åã³ããææçCOVID-19蚺æã®æåŒããã«èšèŒãããŠããæ²»çè¬ã§ãããèªå®
æŸçœ®ã®æ¹ã«ã¯æ©æã®æ²»çè¬ãšããŠäœ¿ã£ãŠãããã°ãå¿
ãæããåœããããŸãã
äœæ
ãWHOãå察ããŠããââ
圌ãã¯DSãããããããã£ãŠããããã§ãããâŒïž
圌ãã¯DSãããããããã£ãŠããããã§ãããâŒïž
å©æš©ã絡ãã§ãããã âŒïž
AERAã¯ã€ãã«ã€ãã«ã¡ã¯ãã³ ãããåãæµãã ããããæ²»éšãã£ãŠå¹æãã§ãªãã®ã ããé°è¬è«ã®ä»ãå
¥ãéã¯ããããææ©ææ¥æ°èã°ã«ãŒãã¯ååšèªäœã瀟äŒæªã人é¡ã®æµãææ¥æ°èã°ã«ãŒãã«å€ããŠããããšãæ¥ããã
ãããŠïœ€ã€ãã«ã¡ã¯ãã³ã®é
åžãã§ããã°å®ç§ã
æ²»éšäžã®ã¯ã¯ãã³ãããå¹æã®åºãŠããè¬ã®æ¿èªãæ±ããŸãïŒ
ã¯ã¯ã¯ã¯ã¡ããèŠããªããããw
ãªãã§ïŒãªãã§ç¬ã®ãã£ã©ãªã¢ã®é§è«è¬ãã³ããã«å¹ãã®ïŒ
æåã«æ°ã¥ãã人ãããããããð
æåã«æ°ã¥ãã人ãããããããð
äžåœè£œåãããªãããã§ããïŒ
äžåœã¯ã¯ãã³ãèªããŠãŸãããïŒ
ã®ã£ã°ãã
äžåœã¯ã¯ãã³ãèªããŠãŸãããïŒ
ã®ã£ã°ãã
å¹ããŠã
æ°åã³ããïŒã€ã³ãïŒ5æãéããŠããããã®ç¶æ³ã«å€åãçããŠãããåå·ãæå¯çè«ç
ã®ç¹å¹è¬ãã€ãã«ã¡ã¯ãã³ãã®æ¬æ Œæäžã«èžã¿åã£ãŠãããææè
æ°ã»æ»äº¡è
æ°ãšãã«æžå°ã«è»¢ããŠãã
æ©ãèªå®
åŸ
æ©ãããã«åŸ
æ©ã®æ£è
ãžé
ããããã«ãã¹ãã ïŒ
ã¢ã«ãç³»åã®èšäºã¯ä¿¡çšã§ããªããã€ãã«ã¡ã¯ãã³ã¯å¥ãWHOãªããã¯ãœçšã®åœ¹ã«ãç«ãããŒãã ããæ¯ãåã£ãŠèªèšŒé²ããããã
ãŸãå人çã«ã¯ã¯ã¯ãã³ãã1000000000000åãå®å
šã ãšæãã
ã€ã³ãã¯ãã¥ãŒããªãŒãææè æ°æ¿æžããŠãŸããã
ã€ã³ãã¯ãã¥ãŒããªãŒãææè æ°æ¿æžããŠãŸããã
ã¢ããªã«ã§ææè
ãæäžããã®åœã10äžäººåœãã131人
ãæäžãªãã®åœãã925人
æ»äº¡è æ°ã¯ã
ã»æäžåœã10äžäººåœãã2.1人
ã»æäžããŠããªãåœã¯28ã»4人
ãæäžããã®åœã10äžäººåœãã131人
ãæäžãªãã®åœãã925人
æ»äº¡è æ°ã¯ã
ã»æäžåœã10äžäººåœãã2.1人
ã»æäžããŠããªãåœã¯28ã»4人
ãã£ã¡ã®æ¹ãè¯ãããããª(ã.ã)
å¯äœçšå°ãªããããã³ãã³äœ¿ããããã«ãããYO(^o^)ïŒ
å¯äœçšå°ãªããããã³ãã³äœ¿ããããã«ãããYO(^o^)ïŒ
ãã®èšäºã®çåœã¯ãããã§ããããïŒ
Σãœ(ïŸÐïŸ; )ïŸ
ã€ã³ãã§ã®çŸç¶
ãæ°èŠææè
ã10åã®1ãã15åã®1ãŸã§æžå°ããã®ã§ãããã®åŸã«å€§çµ±é ãå€ãã£ãŠããã«ãŒã§ã¯æäžããªãæ¹éã«è»¢ããŸããããåã³ææè
æ°ãæ¥å¢ã
ããã»ã©æãããªå¹æãããã®ã«èªããªãWHO
ããã»ã©æãããªå¹æãããã®ã«èªããªãWHO
ã¢ããªã«è«žåœ
â¯ã€ãã«ã¡ã¯ãã³ãæäžããåœ
ææè æ° 131人/10äžäºº
æ»äº¡è æ° 2.1人/10äžäºº
â¯æäžãªãã®åœ
ææè æ° 925人/10äžäºº
æ»äº¡è æ° 28.4人/10äžäºº
â¥ãšãå¹æã®å·®ã¯13å以äž
å°åºŠããã«ãŒã§ãåãæ§ãªçµæã«ð
ã€ã³ããã³ããæ²»çã§ææè æ°æž
â¯ã€ãã«ã¡ã¯ãã³ãæäžããåœ
ææè æ° 131人/10äžäºº
æ»äº¡è æ° 2.1人/10äžäºº
â¯æäžãªãã®åœ
ææè æ° 925人/10äžäºº
æ»äº¡è æ° 28.4人/10äžäºº
â¥ãšãå¹æã®å·®ã¯13å以äž
å°åºŠããã«ãŒã§ãåãæ§ãªçµæã«ð
ã€ã³ããã³ããæ²»çã§ææè æ°æž
ã€ãã«ã¡ã¯ãã³WHOãå察ããªã?
ã¢ã¡ãªã«ã§äœ¿çšçŠæ¢ã
ã¯ã¯ãã³æšé²ã®çç±ã¯?
ã¢ã¡ãªã«ã§äœ¿çšçŠæ¢ã
ã¯ã¯ãã³æšé²ã®çç±ã¯?
ã¯ã¯ãã³éã«åããªããŠããæ²»çè¬ããããªããèªããŠããããšå¿åŒ·ãã®ã ããã
審è°äžïŒ
æ¥æ¬çºã ã ã€ã³ããã³ããæ²»çã§ææè
æ°æžãWHOãå察ãã®ããŒãdot.ã
WHOãCDCãèšã£ãŠãããããšããçç±ã ãã§å察ããã®ã¯ããããããŠããã ãããã§ã--WHOã¯ä»¥åããã¹ã¯ã¯èŠããªããšããæ¹éããšã£ãŠããŸããããä»ã¯äžè»¢ããŠãã¹ã¯ãéèŠã ãšèšã£ãŠããŸã
ã³ããã«å¯ŸããŠã€ãã«ã¡ã¯ãã³ã®å¹æãã€ã³ãã»ãã«ãŒã»ã¢ããªã«è«žåœã§åºãŠããããã§ããã
åå·ãæå¯çè«ç
ã®ç¹å¹è¬ãã€ãã«ã¡ã¯ãã³ãã®æ¬æ Œæäžã«èžã¿åã£ãŠãããææè
æ°ã»æ»äº¡è
æ°ãšãã«æžå°ã«è»¢ããŠããð
ãã®ã€ãã«ã¡ã¯ãã³ãã¢ãã¬ã³çã®æªæ¿èªãã³ããéçè
æ°å¢ã®äžå ãšãªã£ãŠããäºãäœæ
ã¯ããŒãºã¢ãããããªããã ïŒ
åçåŽåçã®çœªã¯éãã
åçåŽåçã®çœªã¯éãã
æ°åã³ããã«ã¯ãã¯ã¯ãã³ããã
ãã€ãã«ã¡ã¯ãã³ãã§ææå¢æ®ãæããæ¹ãå®å šã§å¹æãããæ§ã§ãðð§
äžéšã®åœã§ã¯ã€ãã«ã¡ã¯ãã³ã®å¹æãçºæ®ãããŠããâšæ¥æ¬ã
åºç€å®éš/èšåºå®éšãçããéºäŒåã¯ã¯ãã³
ãã
ã€ãã«ã¡ã¯ãã³ãæ¿èª/䜿çšããã¹ãã§ã¯?
ãã€ãã«ã¡ã¯ãã³ãã§ææå¢æ®ãæããæ¹ãå®å šã§å¹æãããæ§ã§ãðð§
äžéšã®åœã§ã¯ã€ãã«ã¡ã¯ãã³ã®å¹æãçºæ®ãããŠããâšæ¥æ¬ã
åºç€å®éš/èšåºå®éšãçããéºäŒåã¯ã¯ãã³
ãã
ã€ãã«ã¡ã¯ãã³ãæ¿èª/䜿çšããã¹ãã§ã¯?
ãããæ¬åœã«å¹æãããšãããªããå¯äœçšãäžå®ãªã¯ã¯ãã³ãã€ããå人çã«ããæ¥æ¬ã®ããã«ãè¯ãã
é§è«è¬äœ¿ã£ããè¯ãããªãã§ããã
å¹æãããŸããããã
ãããææçŽåŸãããããããããªã䜿ããªãã
å¹æãããŸããããã
ãããææçŽåŸãããããããããªã䜿ããªãã
æ¥æ¬ã§ãæ²»éšãé²ãæ©æ¥ã«æ¿èªãïŒ
ããããè¶ãªãããå¹ããã§ããïŒ
åãïŒ
以äžã®èšäºã§ãã€ã³ãã«ãããŠã€ãã«ã¡ã¯ãã³ãå¹æãã£ããšæžãããŠããã§ããâŠ
ãããæ¥æ¬ã§ã¯ãããŸã§å¯äœçšãªãïŒ
äœã§é ãªã«ã¯ã¯ãã³ãªã®ããããããéªæšããŸãããâŠ
åãïŒ
以äžã®èšäºã§ãã€ã³ãã«ãããŠã€ãã«ã¡ã¯ãã³ãå¹æãã£ããšæžãããŠããã§ããâŠ
ãããæ¥æ¬ã§ã¯ãããŸã§å¯äœçšãªãïŒ
äœã§é ãªã«ã¯ã¯ãã³ãªã®ããããããéªæšããŸãããâŠ
å¹æããããã§ããªã
ã€ãã«ã¡ã¯ãã³ïŒ
ã€ãã«ã¡ã¯ãã³ïŒ
ã€ãã«ã¡ã¯ãã³ãã€ã³ãã§å¹æåºããã ãªâŠ
ã¯ã¯ãã³ãªãããããããâŠ
ãªãã§ã€ãã«ã¡ã¯ãã³ãèªããªãã®ïŒ
ãã¯ãåœãããéã倧äºãªã®ããâŠ
ã¯ã¯ãã³ãªãããããããâŠ
ãªãã§ã€ãã«ã¡ã¯ãã³ãèªããªãã®ïŒ
ãã¯ãåœãããéã倧äºãªã®ããâŠ
ã äžçäžã§å¹æå®èšŒæžã¿ æ¿èªãå·¡ã£ãŠãå©çãã¡ãŒã¹ããåœãã¡ãŒã¹ãããã§äžçãåæããŠããªããŠç¥ããªãã£ãã
ãæ©ææ¿èªãããŠèªå® çé€æ£è ã«æäžã§ããããã«ãªã£ãŠæ¬²ããã
ð»èªå£²æ°èð»
ð»AERAð»
ãæ©ææ¿èªãããŠèªå® çé€æ£è ã«æäžã§ããããã«ãªã£ãŠæ¬²ããã
ð»èªå£²æ°èð»
ð»AERAð»
ã€ãã«ã¡ã¯ãã³ãšããéžæè¢ã¯ã©ããªãã ããã
â人ã次ã
ãšåœãèœãšããŠããæäºã®äžã§ããEBMïŒæ ¹æ ã«åºã¥ãå»çïŒãå¿
èŠã ããšèšã£ãŠäœå人äœäžäººã®ããŒã¿ãèŠæ±ãããããªèãã¯ãããããšæã£ãŠããŸãã â
ïŒ
ïŒ
>>人ã次ã
ãšåœãèœãšããŠããæäºã®äžã§ããEBMïŒæ ¹æ ã«åºã¥ãå»çïŒãå¿
èŠã ããšèšã£ãŠäœå人äœäžäººã®ããŒã¿ãèŠæ±ãããããªèãã¯ãããããšæã£ãŠããŸãã
ïŒç¶ãïŒ
ïŒç¶ãïŒ
å¯äœçšæžå¿µããªã沢山ã®äººã«äœ¿ããè¬ãçµæææãæžãçŸå®ãæ¥æ¬çºã®ã€ãã«ã¡ã¯ãã³ãã¢ãã¬ã³ãäœæ
æ¥æ¬ã§ç©æ¥µçã«ãããªãã®ããå©æš©ããåœçã«ãªãåŸã
åœæ°ç掻ããç·æ¥æããªã®ã«ãæ¥æ¬æ¿åºã®å¯Ÿå¿ã¯ããã€ããå¹³æã
ç¶æ³ãç®ã«èŠããŠæªåããªãéãåããªãããããã€ããåŸæã
ã©ãã ãç ç²ãåºãããæžããã ããâŠ
ç¶æ³ãç®ã«èŠããŠæªåããªãéãåããªãããããã€ããåŸæã
ã©ãã ãç ç²ãåºãããæžããã ããâŠ
äžçã®ãã¡ãã¡ã§å¹æãèªããããŠããã€ãã«ã¡ã¯ãã³ãéçºåœã®æ¥æ¬ã§ãæ¬æ Œçã«äœ¿çšã§ããããã«ããŠã»ãã
äºè
æäžã ã£ãããå¥åº·ãªäœã«æ¥ããããã®ã¯ã¯ãã³ãæã€ããã倧æå士ãéçºããã€ãã«ã¡ã¯ãã³ã§æ²»çã®æ¹ãå®å¿æããããŸãã
ã€ãã«ã¡ã¯ãã³ã䜿ã£ãŠã»ãã
ã€ãã«ã¡ã¯ãã³ãæ¯éïŒ
WHOãå察ããã£ãŠããšã¯æ£ãããã ãããª
âââââ
âââââ
ã€ãã«ã¡ã¯ãã³ã䜿ã£ãŠãã ãã
äž»èŠã¡ãã£ã¢ã§ã¯ã€ã³ãå»åž«1200人æ»äº¡ã®ãã¬ãã£ããã¥ãŒã¹ã絶è³æ¡æ£äžã§ããâŠ
æ¢ã«5/7ãããŒã¯ã«åæžããŠããŸã
æ¢ã«5/7ãããŒã¯ã«åæžããŠããŸã
Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments
ã€ã³ãã§ã¯æ¥æ¬ã®ã€ãã«ã¡ã¯ãã³ã®å¹æãããŒã¿ã§åºå§ããŠããŸãã
ã€ã³ãã§ã¯æ¥æ¬ã®ã€ãã«ã¡ã¯ãã³ã®å¹æãããŒã¿ã§åºå§ããŠããŸãã
ããŒãã«è³åè³ã®å€§æå
çã®ã€ãã«ã¡ã¯ãã³ãå¹ããŠãããã§ã€ã³ãã§ææè
æžå°ãããã§ããè¯ã話ã
ãªãããã
ããããå æžæ¬åœã®ããšãç¥ãããŠããã人ãããŒã®ïŒ
ããããå æžæ¬åœã®ããšãç¥ãããŠããã人ãããŒã®ïŒ
ã€ãã«ã¡ã¯ãã³ïŒïŒ
ã€ã³ãã§çµæãåºå§ããŠãŸããð
ã€ã³ãã§çµæãåºå§ããŠãŸããð
ååŽçãäœãšãèšãâŒïžð¢ â
WHOãå察ãšããããšã¯æå¹æ§ããããšããããšïŒ
ã€ã³ã¿ãã¥ãŒèšäºãåé倧åŠææã»å€§ææºèšå¿µç 究æææå¶åŸ¡ç 究ã»ã³ã¿ãŒé·ã®è±æšç§ææ°
ææè
ãæ»è
ãæ¥æ¿ã«å¢ããã€ã³ãã§ãæ¥æ¬çºã®ã€ãã«ã¡ã¯ãã³ã䜿çšãããææè
ãæžã
NHKã¯ãå ±éããªããããTwitterã§æ¡æ£äžã
NHKã¯ãå ±éããªããããTwitterã§æ¡æ£äžã
éåžžäºæ
ã®ã€ã³ãã§ã¯äœ¿ãã¹ããäœãå¹æçããåãããªãç¶æ³ãªã®ã ããããŸãåºæ¬çã«WHOã¯æ°ã«ããå¿
èŠãªãã§ããã
ç¥äºããã®æ
å ±ãç¥ããªãèš³ããããŸããããã
ã¯ã¯ãã³ãããã
ã¯ã¯ãã³ããç¡ã
ã®å¯Ÿå¿ã¯ãããããšæããŸããã
ã¯ã¯ãã³ãããã
ã¯ã¯ãã³ããç¡ã
ã®å¯Ÿå¿ã¯ãããããšæããŸããã
ã»ã»ã»ã€ãã«ã¡ã¯ãã³ããã¯ã¯ãã³ãæ®åããããèš³ã¯ã¯ã¯ãã³ã®æ¹ã補è¬äŒç€Ÿãå²ããããã ãšèšãããŠãŸããã人éã¯èªæã«åŒ±ãçãç©ã ã
ã€ã³ãã¯ã€ãã«ã¡ã¯ãã³ã®å¹æãçŸããŠãããšèŠãŠè¯ãããšð
äœåºŠãèšã£ãŠããã©ãå»ç厩å£ã ïŒãšèšãåã«ãæ¥æ¬ã®å»è
ã¯åºæ¥ãããšããããªããã
ã€ã³ããèŠç¿ãããšã
ã€ã³ããèŠç¿ãããšã
ã€ã³ããã³ããæ²»çã§ææè
æ°æž
æ¥æ¬çºãã€ãã«ã¡ã¯ãã³ã
æ¥æ¬çºãã€ãã«ã¡ã¯ãã³ã
ããããã°å»å¹Žãã®è¬ã¯ã³ããã«å¹ããšå€§ææº(åé倧ç¹å¥æ èªææãçºèŠãéçºãã2015幎ã«ããŒãã«å»åŠççåŠè³ãåè³ããæå¯çè«è¬)ããã確ããã¬ãåºãŠèšã£ãŠãã®èŠããª
ã¯ã¯ãã³ã®æ¿èªã¯ãããæ©ãã®ã«ãå¹æãããããªæ²»çè¬ã¯æ¿èªãããªããäžæè°ãäžæè°ã
ãªããåããªãã¢ãã¬ã³ã»ã©ç¥çµè³ªã«ãªããã§ãè¯ãã®ããð§
ãŸããWHOã§ããããäžåœæ§ã®ãæ©å«ã䌺ããªããšãããªããã§ãããïŒé©åœã§ãïŒã
ãæ¥æ¬ã®æ²»çè¬ã
ã€ã³ãã§ã³ããæ²»çã«äœ¿çšãå¹æãçŸããŠãããæ¥æ¬ã§ã¯å šãå ±éãããŠããªããâŠð
ã€ã³ãã§ã³ããæ²»çã«äœ¿çšãå¹æãçŸããŠãããæ¥æ¬ã§ã¯å šãå ±éãããŠããªããâŠð
åã
ãããŠã¯ãµãããŠã¯ãããã©ã
ãã£ãšãæ¥æ¬äººã«ã¯IGGæäœãåºãå ç«åããããå¿ èŠãªããšã¯æããã©